Simplex Trading’s Precision BioSciences DTIL Stock Holding History

Simplex Trading’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2K	Buy	+1,300	New	+$9.15K	﹤0.01%	7681
2022 Q3	–	Sell	-220	Closed	-$10K	–	10101
2022 Q2	$10K	Buy	220 +140	+175%	+$8.22K	﹤0.01%	8275
2022 Q1	$7K	Sell	80 -67	-46%	-$9.1K	﹤0.01%	9156
2021 Q4	$32K	Sell	147 -6	-4%	-$1.68K	﹤0.01%	7811
2021 Q3	$58K	Hold	153	–	–	﹤0.01%	7336
2021 Q2	$57K	Buy	153 +151	+7,550%	+$45.4K	﹤0.01%	7478
2021 Q1	$71K	Buy	+2	New	+$700	﹤0.01%	6185
2020 Q2	–	Sell	-2	Closed	-$36K	–	7744
2020 Q1	$36K	Buy	2 +1	+100%	+$262	﹤0.01%	5459
2019 Q4	$52K	Buy	+1	New	+$314	﹤0.01%	5141

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Simplex Trading's DTIL Position: Q2 2026 in Review

Simplex Trading reduced its Precision BioSciences (DTIL) stake by 45% in Q2 2026, selling an estimated $11K and leaving 1,942 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #7338.

Simplex Trading first reported a position in DTIL in Q1 2020 and has held it in 15 quarters since. The position peaked at $69K in Q3 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Simplex Trading held 1,942 shares of Precision BioSciences worth $15.3K as of Q2 2026.
Simplex Trading sold 1,570 Precision BioSciences shares in Q2 2026, an estimated $11K.
Precision BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7338 holding.
Simplex Trading first reported a position in Precision BioSciences in Q1 2020 and has held it in 15 quarters since.
Simplex Trading's Precision BioSciences position peaked at $69K in Q3 2021.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.